Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. (Q53657205)
Jump to navigation
Jump to search
scientific article published in April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. |
scientific article published in April 2003 |
Statements
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. (English)
1 reference
Donald Trump
1 reference
George Wilding
1 reference
Edward M Messing
1 reference
Judith Manola
1 reference
Kathleen Propert
1 reference
Jonathan Fleischmann
1 reference
E David Crawford
1 reference
J Edson Pontes
1 reference
Richard Hahn
1 reference
Eastern Cooperative Oncology Group/Intergroup trial
1 reference
1 April 2003
1 reference
21
1 reference
7
1 reference
1214-1222
1 reference
Identifiers
1 reference